Free Trial

Mubadala Investment Co PJSC Purchases New Holdings in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Mubadala Investment Co PJSC bought a new position in shares of Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 56,371 shares of the business services provider's stock, valued at approximately $2,421,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Tealwood Asset Management Inc. grew its holdings in Genpact by 1.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider's stock valued at $1,059,000 after purchasing an additional 339 shares during the last quarter. Burney Co. grew its stake in Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock valued at $5,618,000 after acquiring an additional 92,641 shares during the last quarter. Sawyer & Company Inc increased its holdings in Genpact by 2.7% during the 4th quarter. Sawyer & Company Inc now owns 37,213 shares of the business services provider's stock valued at $1,598,000 after acquiring an additional 970 shares in the last quarter. Wedge Capital Management L L P NC raised its position in Genpact by 6.5% during the fourth quarter. Wedge Capital Management L L P NC now owns 46,179 shares of the business services provider's stock worth $1,983,000 after acquiring an additional 2,830 shares during the last quarter. Finally, HB Wealth Management LLC lifted its holdings in shares of Genpact by 18.9% in the fourth quarter. HB Wealth Management LLC now owns 10,224 shares of the business services provider's stock valued at $439,000 after purchasing an additional 1,627 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Robert W. Baird dropped their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Needham & Company LLC cut their target price on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Genpact currently has an average rating of "Hold" and an average price target of $50.71.

Check Out Our Latest Stock Report on Genpact

Insider Activity at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. This represents a 4.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nicholas C. Gangestad bought 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the acquisition, the director now owns 2,000 shares in the company, valued at approximately $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is owned by insiders.

Genpact Trading Up 0.9%

Genpact stock traded up $0.41 during trading on Friday, hitting $44.28. The company's stock had a trading volume of 2,286,869 shares, compared to its average volume of 1,368,521. The stock's fifty day moving average is $48.02 and its 200 day moving average is $47.19. Genpact Limited has a 1-year low of $30.38 and a 1-year high of $56.76. The stock has a market capitalization of $7.74 billion, a price-to-earnings ratio of 15.59, a P/E/G ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same period in the prior year, the firm posted $0.73 EPS. The company's revenue was up 7.4% on a year-over-year basis. As a group, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines